Sign in

CIK 0001430306

  • Non-accelerated filer
  • Smaller reporting company

Tonix Pharmaceuticals Holding Corp.

Sign in to watch
Ticker
TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
261434750
Phone
+1 212-980-9155
Business address
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
Former names
TAMANDARE EXPLORATIONS INC.
  1. 4 Open-market buy CFO and Treasurer bought 200 shares at $7.49 ($1,498)
  2. 4 Open-market buy DAUGHERTY BRUCE bought 100 shares at $7.47 ($747)
  3. 4 Open-market buy DAUGHERTY BRUCE bought 200 shares at $7.48 ($1,496)
  4. 4/A Open-market buy CFO and Treasurer bought 100 shares at $7.49 ($749)
  5. 4 Open-market buy CFO and Treasurer bought 100 shares at $7.49 ($749)
  6. 4 Open-market buy Chief Executive Officer bought 1,000 shares at an average $7.30 ($7,300)
  7. 4 Conversion Director acquired 166,667 shares (conversion)
  8. 4 Conversion Director acquired 166,667 shares (conversion)
  9. 4 Conversion Director acquired 25,000 shares (conversion)
  10. 4 Conversion Director acquired 166,667 shares (conversion)
  11. 4 Conversion CFO and Treasurer acquired 37,500 shares (conversion)
  12. 4 Conversion Director acquired 166,667 shares (conversion)
  13. 4 Conversion DAUGHERTY BRUCE acquired 37,500 shares (conversion)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 18 of 19 · 376 filings